What we're reading, May 26, 2016: South Carolina passes a 20-week abortion ban, while Georgia's own law faces a new challenge; the FDA delays its decision on a controversial drug for Duchenne muscular dystrophy; and report highlights how Cover Oregon was mishandled.
In South Carolina, a new bill signed into law makes abortion after 20 weeks illegal; meanwhile, in Georgia, a new challenge is being brought against the state's own 20-week abortion ban. The bill signed by South Carolina Governor Nikki Haley makes the law take effect immediagely with abortions only allowed after 20 weeks if the mother's life is in danger, according to CNN. There are no exceptions for rape or incest. The law in Georgia is similar: making an exception to protect the life of the mother, but not for rape or incest. However, the Georgia law also allows for abortion if the fetus has a defect so severe that it is unlikely to live. In 2012, when the law was passed, the American Civil Liberties Union filed a lawsuit and was not informed that the case had been dismissed, reported ABC News. The lawyers are now fighting to suspend the law while they continue to fight it.
The FDA delayed its decision on whether or not to approve a controversial drug to combat Duchenne muscular dystrophy. STAT reported that this is the second time the agency has extended its time to decide on approving the treatment and there is speculation that the delays appear to reflect political pressure. Patients groups and lawmakers want the FDA to transform the process for approving new medical products, especially for diseases with unmet needs, but an FDA advisory panel last month voted not to recommend approving the medication.
Republicans on a US House committee released a report on the mishandling of Oregon’s health insurance website. The Republicans are asking for a criminal investigation regarding actions involving Cover Oregon and the millions of taxpayer dollars that were wasted, according to AP. The Republicans are claiming state officials misused federal money, but Democrats on the committee are blaming the state’s contractor for the trouble with the website, which failed to enroll a single person online.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More